ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Anti-CD321 Antibody (90G4) Protects Liver against Ischemia Reperfusion Injury in a Murine Model

E. Yin1, T. Fukuhara2, H. Bashuda1, K. Uchida3

1Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan, 2Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan, 3Juntendo Advanced Research Institute for Health Science, Juntendo University School of Medicine, Tokyo, Japan

Meeting: 2020 American Transplant Congress

Abstract number: B-340

Keywords: Adhesion molecules, Antibodies, Ischemia, Liver

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session B: Ischemia Reperfusion & Organ Rehabilitation

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • An Immune-Modulatory Strategy to Mitigate Hepatic Ischemia Reperfusion/Injury in a Murine Model
  • Galectin-9 Protects Mouse Liver Transplants Against Ischemia-Reperfusion Injury

*Purpose: Ischemia reperfusion results in increased transmigration of leukocytes into tissue. This eventually leads to post transplant graft damage after organ transplantation. CD321 (also known as Junctional Adhesion Molecule-A, JAM-A), which is expressed in endothelial tight junctions, and its ligand lymphocyte-function-associated antigen-1 (LFA-1) are demonstrated to be involved in transmigration of leukocyte. This study was designed to investigate the effect of intraportal administration of Anti-CD321 monoclonal antibody (90G4) with regard to liver injury in a murine model of liver warm ischemia reperfusion injury.

*Methods: Warm ischemia of 60 minutes is produced by a micro vessel clip in the 70% of the whole liver in C57BL/6 mouse and followed after reperfusion. 300 μg/mouse of 90G4 or IgG was injected from the portal vein after removing the clip. Serum was collected for liver enzyme and cytokine detection, meanwhile, damaged liver was analyzed by pathology, immunohistochemical staining and flow cytometry.

*Results: The expression of CD321 was internalized in sham group, however, expressed more obvious after liver IRI on the wall of vessels. The levels of GOT and GPT in 90G4 treatment group were significantly decreased compared with IgG group. Moreover, tissue damage observed by histologic study (Suzuki score, cleaved Caspase 3 staining, and TUNEL staining) was consistent with above results. The neutrophil recruitment into the liver were inhibited in 90G4 treatment group after reperfusion. And systemic levels of IL-6 and TNF-α were remarkably reduced in 90G4 group accordingly.

*Conclusions: Intrapotal injection of 90G4 ameliorates ischemia reperfusion injury in a murine model and may provide a potential antibody therapeutics in clinic.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yin E, Fukuhara T, Bashuda H, Uchida K. Anti-CD321 Antibody (90G4) Protects Liver against Ischemia Reperfusion Injury in a Murine Model [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/anti-cd321-antibody-90g4-protects-liver-against-ischemia-reperfusion-injury-in-a-murine-model/. Accessed February 25, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.